Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients (Q35226905)

7 August 2017

1 reference

title

Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients (English)

1 reference

7 August 2017

0 references

1 reference

Tjaard U Hoogenraad

1

1 reference

7 August 2017

22 September 2011

1 reference

International journal of Alzheimer's disease

7 August 2017

1 reference

7 August 2017

2011

1 reference

7 August 2017

492686

1 reference

Creative Commons Attribution 3.0 Unported

7 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Association studies for next-generation sequencing

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Biomarkers of Alzheimer's disease: from central nervous system to periphery?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

GENOME-WIDE ASSOCIATION MAPPING AND RARE ALLELES: FROM POPULATION GENOMICS TO PERSONALIZED MEDICINE - Session Introduction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Copper transport to the brain by the blood-brain barrier and blood-CSF barrier

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

How reliable and robust are current biomarkers for copper status?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Advances in the early detection of Alzheimer's disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Ceruloplasmin metabolism and function

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Evidence for uptake of nonceruloplasminic copper in the brain: effect of ionic copper and amino acids.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice

13 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Different protective roles in vitro of alpha- and beta-domains of growth inhibitory factor (GIF) on neuron injuries caused by oxygen free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Excess of serum copper not related to ceruloplasmin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Dietary copper and high saturated and trans fat intakes associated with cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178199

Copper-mediated formation of hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?

26 September 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F492686

21 January 2018

Identifiers

DOI

10.4061/2011/492686

1 reference

release_vz5hhkliuza6jjhw7c44e6zidm

7 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vz5hhkliuza6jjhw7c44e6zidm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

3178199

1 reference

7 August 2017

1 reference

PubMed ID

21949909